<DOC>
	<DOCNO>NCT02513121</DOCNO>
	<brief_summary>This investigator initiate study conduct equal number two site , UC San Diego Emory University . The purpose study understand potential low sugar diet treatment nonalcoholic fatty liver disease ( NAFLD ) child . Forty boys NAFLD randomly assign either intervention group habitual diet control group . The intervention low sugar diet period 8 week . The effect dietary change assess use advanced MRI test measure liver fat .</brief_summary>
	<brief_title>Dietary Treatment Study Pediatric NAFLD</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Boys age 1116 year inclusive . Clinical history consistent NAFLD . Biopsyproven NAFLD MRI measure Liver Proton Density Fat Fraction ≥10 % ALT ≥ 45 u/L No evidence liver disease clinical history histological evaluation . Written inform consent parent legal guardian . Written inform assent child adolescent . Exclusions base upon gender , race , ethnicity . Participants current history follow condition health issue make unsafe participate opinion Investigators exclude study : History significant alcohol intake ( AUDIT questionnaire ) inability quantify alcohol consumption Chronic use ( 2 consecutive week ) medication know cause hepatic steatosis steatohepatitis past year . The use know hepatotoxin within 120 day baseline History total parenteral nutrition ( TPN ) use year prior screen History bariatric surgery planning undergo bariatric surgery study duration Significant depression Noncompensated liver disease one follow hematologic , biochemical , serological criterion entry protocol : Hemoglobin &lt; 10 g/dL White blood cell &lt; 3,500 cells/mm Neutrophil count &lt; 1,500 cells/mm3 blood Platelets &lt; 130,000 cells/mm3 blood Direct bilirubin &gt; 1.0 mg/dL Total bilirubin &gt; 3 mg/dL Albumin &lt; 3.2 g/dL International normalized ratio ( INR ) &gt; 1.4 Evidence chronic liver disease Children currently enrol clinical trial receive investigational study drug medication intent treat NAFLD/NASH past 60 day Contraindications MRI , e.g . metal eye , implant electronic device , aneurysm clip , pacemaker , cochlear implant Unable complete MRI exam due body weight exceed scanner table limit girth exceed scanner bore diameter Subjects able willing comply protocol condition would impede compliance hinder completion study , opinion investigator Families &gt; 5 individual Failure give inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>Steatohepatitis</keyword>
	<keyword>NASH</keyword>
	<keyword>Liver</keyword>
	<keyword>Diet</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Adolescent</keyword>
</DOC>